| Literature DB >> 20529214 |
Arnaldo C Porto Neto1, Rafael D'Agostini Annes, Nathalia Mm Wolff, Andréia P Klein, Francisco C Dos Santos, Juliana L Dullius, Marina Gressler, Letícia S Muller, Cristine F Angonese, Sérgio Menna-Barreto.
Abstract
The objective of this study was to investigate the prevalence and severity of asthma, rhinitis, and atopic eczema in schoolchildren from southern Brazil. A cross-sectional study was carried out with the International Study of Asthma and Allergies in Childhood phase III written questionnaire. The questionnaire was self-applied by 2,948 randomly selected schoolchildren aged 13 to 14 years. The lifetime prevalence rates of symptoms were as follows: wheezing, 40.8%; rhinitis, 40.7%; eczema, 13.6%; self-reported asthma, 14.6%; rhinitis, 31.4%; eczema, 13.4%. Rhinitis was reported by 55% of adolescents with current asthma (60% females vs 46.9% males). Girls 13 to 14 years of age had higher prevalence rates of asthma, rhinitis, and eczema than boys had. Atopic eczema was reported by 42.7% of girls and 31.4% of boys with asthma. The prevalence rates were statistically significant for symptoms of asthma, rhinitis, and atopic eczema in females. However, there were no statistically significant differences between the sexes in regard to reported asthma and bronchospasm induced by exercise.Entities:
Year: 2006 PMID: 20529214 PMCID: PMC3231648 DOI: 10.1186/1710-1492-2-1-3
Source DB: PubMed Journal: Allergy Asthma Clin Immunol ISSN: 1710-1484 Impact factor: 3.406
Self-Reported Prevalence of Asthma, Rhinitis, and Eczema and Their Related Symptoms in 13- to 14-Year-Old Schoolchildren
|
|
|
|
| ||
|---|---|---|---|---|---|
|
| (n = | (n = | (n = |
| p |
| Asthma | |||||
| Ever wheezed | 43.6 | 37.8 | 40.8† | 1.27 (1.09-1.48) | <.01 |
| Wheeze in the past year | 23.1 | 17.7 | 20.5† | 1.40 (1.16-1.69) | <.001 |
| Wheezing with exercise last year | 22.9 | 20.1 | 21.5 | 1.18 (0.98-1.41) | >.05 |
| Persistent cough last year | 47.1 | 31.3 | 39.4† | 1.96 (1.68-2.29) | <.001 |
| Ever had asthma | 13.5 | 15.7 | 14.60 | 0.83 (0.67-1.03) | >.05 |
| Rhinitis | |||||
| Ever had rhinitis | 47.1 | 34.0 | 40.7† | 1.72 (1.48-2.01) | <.001 |
| Rhinitis in the past year | 35.2 | 23.6 | 29.5† | 1.76 (1.49-2.08) | <.001 |
| Associated itchy eye in | 20.8 | 10.7 | 15.9† | 2.20 (1.78-2.74) | <.001 |
| Ever had allergic rhinitis | 36.5 | 26.1 | 31.4† | 1.63 (1.39-1.92) | <.001 |
| Eczema | |||||
| Chronic rash ever | 15.7 | 11.4 | 13.6† | 1.44 (1.15-1.80) | <.001 |
| Chronic rash in the past year | 10.5 | 6.7 | 8.6† | 1.64 (1.24-2.16) | <.001 |
| Chronic rash with | 6.3 | 3.6 | 5† | 1.84 (1.28-2.65) | <.001 |
| Ever had eczema | 15.3 | 11.4 | 13.4† | 1.40 (1.12-1.74) | <.01 |
CI = confidence interval; n = population size; OR = odds ratio.
*From written questionnaire.
†Indicates significance between girls and boys.
Prevalence of Reported Symptoms Indicating Severity of Asthma, Rhinitis, and Eczema
|
|
|
| ||
|---|---|---|---|---|
|
| (n = | (n = | (n = | p |
| Wheeze in past year | ||||
| Number of wheezing episodes | ||||
| 1-3 | 22.5* | 16.8 | 19.7 | <.01 |
| 4-12 | 1.3 | 1.7 | 1.5 | >.05 |
| >12 | 0.1 | 0.6* | 0.3 | <.01 |
| Awoken by wheeze | ||||
| <1 time each week | 10.9 | 8.9 | 9.9 | |
| ≥1 time each week | 4.8* | 2.6 | 3.8 | <.01 |
| Limitation of speech during wheezing | 6.3 | 3.2 | 4.8 | <.0001 |
| Rhinitis in past year | ||||
| Interference with daily activity | ||||
| Little | 18.2* | 11.9 | 15.1 | <.01 |
| Moderate | 3.8* | 2.4 | 3.2 | <.05 |
| Severe | 2* | 0.8 | 1.4 | <.01 |
| Rashes in past year | ||||
| Persistent rash without clearing | 7.5* | 4.8 | 6.2 | .003 |
| Kept awake by rash | ||||
| <1 time each week | 3.4* | 2.4 | 2.9 | >.05 |
| ≥1 time each week | 1.9* | 0.7 | 1.3 | <.01 |
n = size of sample.
*Indicates significance between girls and boys.
Prevalence of Asthma Symptoms among 52,549 Children Aged 13 to 14 Years, from 17 Latin American Centres
| N | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Cuernavaca | 18°57'N | 3,102 | 18.1 | 6.6 | 4.4 | 2.4 | 5.5 | 4.0 | 13.6 |
| Costa Rica | 9°56'N | 3,200 | 37.6 | 23.7 | 15.2 | 10.1 | 18.5 | 24.2 | 31.1 |
| David, Panamá | 8°26'N | 2,885 | 31.3 | 17.6 | 14.6 | 6.7 | 16.9 | 14.6 | 21.7 |
| Recife | 8°06'S | 3,086 | 39.0 | 19.7 | 13.0 | 4.8 | 20.9 | 20.5 | 30.9 |
| Lima | 12°03'S | 3,158 | 48.6 | 26.0 | 14.1 | 6.9 | 28.0 | 35.9 | 33.6 |
| Salvador | 12°58'S | 3,162 | 44.3 | 27.0 | 9.6 | 5.4 | 12.5 | 27.6 | 29.6 |
| São Paulo | 23°32'S | 3,007 | 45.4 | 23.3 | 12.0 | 2.7 | 10.0 | 20.5 | 33.0 |
| Assunción | 25°15'S | 2,966 | 39.9 | 19.4 | 10.2 | 5.2 | 12.2 | 15.3 | 31.3 |
| Curitiba | 25°24'S | 3,004 | 40.4 | 18.4 | 9.1 | 4.6 | 8.6 | 19.8 | 30.1 |
| Porto Alegre | 30°04'S | 3,195 | 47.0 | 24.7 | 15.2 | 5.7 | 21.9 | 29.0 | 39.2 |
| Rosario | 33°00'S | 3,008 | 23.9 | 11.8 | 7.6 | 4.4 | 7.9 | 16.5 | 41.9 |
| South Santiago | 33°27'S | 3,051 | 27.8 | 11.1 | 7.0 | 4.9 | 11.5 | 25.3 | 32.8 |
| Central Santiago | 33.30'S | 2,944 | 32.3 | 11.7 | 5.3 | 2.0 | 12.4 | 15.0 | 23.1 |
| Buenos Aires | 34°40'S | 2,996 | 19.5 | 9.9 | 6.2 | 3.1 | 6.6 | 13.8 | 36.2 |
| Montevideo | 34°55'S | 3,072 | 31.2 | 19.0 | 9.8 | 5.1 | 15.3 | 18.4 | 28.1 |
| Valdivia | 39°48'S | 3,231 | 22.8 | 11.5 | 5.0 | 2.2 | 11.9 | 18.0 | 16.2 |
| Puntas Arenas | 53°09'S | 3,482 | 21.9 | 6.8 | 3.9 | 1.3 | 7.3 | 6.3 | 15.5 |
| - | 52,549 | 33.6 | 16.9 | 9.5 | 4.5 | 13.4 | 19.1 | 28.6 | |
| Passo Fundo | 28°15'S | 2,948 | 40.8 | 20.5 | 13.7 | 4.8 | 14.6 | 21.5 | 39.4 |
Adapted from Mallol J et al. [27]
ASTHMAEV = asthma ever; AWAKE12 = sleep disturbance from wheeze, 1 or more times a week in the last 12 months; COUGH12 = dry cough at night in the last 12 months;
EXWHEZ12 = wheeze with exercise in the last 12 months; N = size of population; SPEECH12 = wheeze severe enough to limit speech in the 12 months; WHEZEV = wheeze ever;
WHEZ12 = wheeze in the last 12 months.